( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
4043
4016
3910
3721
Total Expenditure
2717
2674
2613
2386
PBIDT (Excl OI)
1326
1342
1297
1335
Other Income
-339
1354
102
924
Operating Profit
987
2696
1399
2259
Exceptional Items
NA
NA
NA
NA
Profit Before Tax
911
2616
1320
2180
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
629
2029
961
1676
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Minority Interest
NA
NA
NA
NA
Shares of Associates
-127
-146
-134
-141
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
502
1883
827
1535
Equity Capital
601
601
600
600
Face Value (IN RS)
10
10
10
10
Calculated EPS
8.35
31.33
13.78
25.58
Calculated EPS (Annualised)
33.41
125.32
55.13
102.33
No of Public Share Holdings
30572260
30572260
30517260
30517260
% of Public Share Holdings
50.88
50.88
50.83
50.83
PBIDTM% (Excl OI)
32.79
33.41
33.17
35.87
PBIDTM%
24.41
67.13
35.78
60.70
PBDTM%
24.26
66.95
35.60
60.44
PBTM%
22.53
65.13
33.75
58.58
PATM%
15.55
50.52
24.57
45.04